Highlights GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:00 18/07/2025 pm IST			5-day change	1st Jan Change
1,348.00 ^GBX	-4.60%		-4.30%	+0.11%

19/07	US FDA advisers recommend against Otsuka's PTSD combination treatment	RE
19/07	Health Care Declines as Traders Hedge on Growth Views - Health Care Roundup	DJ

Highlights

US FDA advisers recommend against Otsuka's PTSD combination treatment	19/07	RE
GSK plc Provides Update on US FDA Advisory Committee Review of Blenrep (belantamab Mafodotin-blmf) Combinations	18/07	CI
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Strong Economic Data	18/07	MT
GSK falls as blood cancer drug likely headed for US rejection	18/07	RE
UK Stocks-Factors to watch on July 18	18/07	RE
US FDA Committee Advises Against Blenrep Combinations for Myeloma	18/07	MT
GSK's blood cancer drug fails to secure US FDA advisers' support	18/07	RE
FDA advisers vote against combination therapies of GSK's blood cancer drug	17/07	RE
US FDA approves GSK's Shingrix in a prefilled syringe presentation	17/07	RE
US FDA approves pre-filled version of GSK's shingles vaccine	17/07	RE
US FDA approves pre-filled version of GSK's shingles vaccine	17/07	RE
US FDA Approves GSK's Shingrix in A Prefilled Syringe Presentation	17/07	CI
GSK wins US approval for prefilled syringe version of shingles vaccine	17/07	AN
GSK Wins US FDA Approval for Prefilled Syringe Presentation of Shingles Vaccine	17/07	MT
FDA staff raises efficacy concerns for Otsuka's PTSD combination treatment	16/07	RE
FTSE 100 retreats from record high as tariff worries resurface	15/07	RE
FDA staff flags eye safety risks for GSK's blood cancer drug	15/07	RE
FDA staff raises eye damage concerns for GSK's blood cancer drug	15/07	RE
GSK-backed ViiV Healthcare Adds Injectable Cabotegravir to HIV Medicines Patent Pool License Deal	15/07	MT
US FDA Accepts Application to Review Expanded Use of GSK's RSV Vaccine, Arexvy, for Adults 18-49 At Increased Risk	14/07	CI
ViiV expands licence to allow generic HIV treatment production for low-income countries	14/07	RE
GSK Seeks FDA Approval to Expand RSV Vaccine Use to At-Risk Adults Aged 18-49	14/07	MT
GSK seeks FDA green light for expanded use of RSV vaccine Arexvy	14/07	AN
UK Stocks-Factors to watch on July 14	14/07	RE
GSK seeks FDA nod for expanded use of RSV vaccine in adults	14/07	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : Despite its challenges, GSK remains investable

May 21, 2025 at 07:38 pm IST

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump

January 14, 2025 at 01:33 am IST

GSK plc : Back on track

May 03, 2024 at 02:47 pm IST